Wayne Shiong
Partner @ China Growth Capital
Beijing, China
Wayne Shiong is a Series A investor at China Growth Capital in Beijing focused on Software and Life Science. Wayne Shiong is the Partner of China Growth Capital. Wayne attended Peking University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Wayne Shiong invests in
Stages Wayne Shiong invests in
Countries Wayne Shiong invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 1 (50%)
- Life Science 1 (50%)
- Biotechnology 1 (50%)
- Information Services 1 (50%)
- Information Technology 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $19M / Series A / Sep 04, 2020 | ||
| Founded in 2016, DeePhi Tech aims to be a recognized leader in deep learning acceleration. They provide end-to-end solutions utilizing deep compression and a DPU platform. Through synergistic optimization of neural networks and FPGAs, DeePhi provides more efficient, convenient and economical inference platforms for both embedded end and sever-side,including but not limited to data centers and surveillance. | $40M / Series A / Oct 24, 2017 |
Co-Investors
About China Growth Capital
China Growth Capital (CGC) is a leading early-stage venture capital firm in China with an extended interest in Silicon Valley. The firm funds seed to Series B in enterprise, technology and marketplace. The typical investment size ranges from $1M to 5M with a hard cap ceiling at $15M per company. Since its founding in 2006, China Growth Capitalhas grown to manage 8 Billion RMB (approximately 1.2 Billion USD) in asset under management across its different RMB and USD funds. Notable portfolio includes SMZDM (300785.SZ), Missfresh (NASDAQ:MF), Wish (NASDAQ:WISH), Tongdun, Tiger Brokers (NASDAQ: TIGR), BeyondHost (now part of Meituan 03690.HK), Ezbuy (NASDAQ:LITB), Cai Cloud (now part of ByteDance), PingCAP, DeePhi (now part of NASDAQ: XLNX), Airlango (now part of HKEX:03690), Nreal, Landspace, WeRide, Plus.ai, Sinovation, Singleron, 4B, ABM Therapeutics and InxMed etc.
China Growth Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Daoping Wang
Partner
|
|||
Haiyan Wu
Managing Partner
|
|||
Ning Tang
Founder
|
|||
|
Wayne Shiong
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Wayne Shiong invest in?
Wayne Shiong invests primarily in Software, Life Science and Biotechnology startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Wayne Shiong?
Public channels for Wayne Shiong include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Wayne Shiong last invest?
The most recent investment recorded for Wayne Shiong closed in Sep 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
